SCHEMBL5500652

SCHEMBL5500652

C=Cc1cc(CN)ccc1NS(C)(=O)=O.C=Cc1cc(CNC(=O)OC(C)(C)C)ccc1NS(C)(=O)=O

nearest known ligand 0.55

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
TRPV1 Q8NER1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2948935 0.95 CA1 (0.43) CA1CA2TRPV1
SCHEMBL5505542 0.89
SCHEMBL2946620 0.82 ADRB3 (0.40) TRPV1
SCHEMBL2959317 0.79 KDM4E (0.44)
SCHEMBL2959315 0.78 HDAC1 (0.43) CA1CA2
SCHEMBL2955340 0.78 NSD2 (0.37) CA1CA2
SCHEMBL5718743 0.77
SCHEMBL5500657 0.77 TRPV1 (0.34) TRPV1
SCHEMBL2948213 0.77 TRPV1 (0.57) TRPV1
SCHEMBL28695516 0.76 TRPV1 (0.50) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1861357-A1 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Amorepacific Corporation (KR) 2007-12-05 EP disclosed
WO-2006101318-A1 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2006-09-28 WO disclosed